|
|
||||||||||||||
|
|
|||||||||||||||
a Department of Medical Oncology, Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, PA 19111, USA, b Department of Molecular Genetics, Biochemistry, and Microbiology, University of Cincinnati, Cincinnati, OH, USA, c Division of Medical Genetics, Department of Pediatrics, The University of Texas Medical School, Houston, TX, USA
Correspondence to: Dr Henske
Revised version received 19 July 1999;
Accepted for publication 30 July
1999
Pulmonary lymphangioleiomyomatosis (LAM) is a rare disorder
limited almost exclusively to women of reproductive age. LAM affects about 5% of women with tuberous sclerosis complex (TSC). LAM also occurs in women who do not have TSC (sporadic LAM). TSC is a tumour suppressor gene syndrome characterised by seizures, mental retardation, and tumours in the brain, heart, and kidney. Angiomyolipomas, which are
benign tumours with smooth muscle, fat, and dysplastic vascular
components, are the most common renal tumour in TSC. Renal
angiomyolipomas also occur in 63% of sporadic LAM patients. We
recently found that 54% of these angiomyolipomas have
TSC2 loss of heterozygosity, leading to the
hypothesis that sporadic LAM is genetically related to TSC. In this
study, we screened DNA from 21 women with sporadic LAM for mutations in
all 41 exons of TSC2. Twelve of the patients
had known renal angiomyolipomas. No TSC2
mutations were detected. We did find three silent
TSC2 polymorphisms. We conclude that
patients with sporadic LAM, including those with renal
angiomyolipomas, do not have a high frequency of germline mutations
in the coding region of TSC2.
This article has been cited by other articles:
![]() |
V. P. Krymskaya Smooth Muscle like Cells in Pulmonary Lymphangioleiomyomatosis Proceedings of the ATS, January 1, 2008; 5(1): 119 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Juvet, F. X. McCormack, D. J. Kwiatkowski, and G. P. Downey Molecular Pathogenesis of Lymphangioleiomyomatosis: Lessons Learned from Orphans Am. J. Respir. Cell Mol. Biol., April 1, 2007; 36(4): 398 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Johnson Lymphangioleiomyomatosis. Eur. Respir. J., May 1, 2006; 27(5): 1056 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ichikawa, A. Wakisaka, S. Daido, S. Takao, T. Tamiya, I. Date, S. Koizumi, and Y. Niida A Case of Solitary Subependymal Giant Cell Astrocytoma: Two Somatic Hits of TSC2 in the Tumor, without Evidence of Somatic Mosaicism J. Mol. Diagn., October 1, 2005; 7(4): 544 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Neal Franz Non-Neurologic Manifestations of Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 690 - 698. [Abstract] [PDF] |
||||
![]() |
A. Astrinidis and E. Petri Henske Aberrant Cellular Differentiation and Migration in Renal and Pulmonary Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 710 - 715. [Abstract] [PDF] |
||||
![]() |
G. Finlay The LAM cell: what is it, where does it come from, and why does it grow? Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L690 - L693. [Full Text] [PDF] |
||||
![]() |
G. A. Finlay, D. S. Hunter, C. L. Walker, K. E. Paulson, and B. L. Fanburg Regulation of PDGF production and ERK activation by estrogen is associated with TSC2 gene expression Am J Physiol Cell Physiol, August 1, 2003; 285(2): C409 - C418. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. STRIZHEVA, T. CARSILLO, W. D. KRUGER, E. J. SULLIVAN, J. H. RYU, and E. P. HENSKE The Spectrum of Mutations in TSC1 and TSC2 in Women with Tuberous Sclerosis and Lymphangiomyomatosis Am. J. Respir. Crit. Care Med., January 1, 2001; 163(1): 253 - 258. [Abstract] [Full Text] |
||||
![]() |
T. Carsillo, A. Astrinidis, and E. P. Henske Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis PNAS, May 23, 2000; 97(11): 6085 - 6090. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |